Ready to learn more about ForeseeHome? Start Here.


Please note ForeseeHome is currently only available in the United States.

SelfSomeone else

YesNo
If yes, please answer the following:

YesNo


Very concernedSomewhat concernedNot concerned at all

Using an Amsler gridTaking vitaminsVisiting an eye doctor regularlyTesting with ForeseeHomeTesting with another at-home monitoring device
All
Subscribe me to your mailing list

By clicking the SIGN UP button below, you agree to receive product and disease-state information from Notal Vision and its affiliates, service providers, and co-promotion partners.

To learn how Notal Vision will use and protect your personal information, please view the Privacy Policy

FDA Indication for Use

The ForeseeHome is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration, as an aid in monitoring progression of disease factors causing metamorphopsia including but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.

The ForeseeHome AMD Monitoring Program is only available by physician order and is intended to be used as an addition to regular eye exams.

The ForeseeHome AMD Monitoring Program is covered by Medicare, subject to its coverage requirements for the test, to assess patients with dry AMD who are at risk of developing wet AMD.